Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2019 021 146.5 |
96 | EP file number | EAKZ | 19 75 1807.9 |
86 | WO file number | WAKZ | PCT/US2019/016918 |
97 | EP publication number | EPN | 3678649 |
87 | WO publication number | WPN | 2019157099 |
54 | Designation/title | TI | INTRANASALE EPINEPHRIN-FORMULIERUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 31/137 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/08 (2006.01), A61K 47/26 (2006.01), A61P 27/14 (2006.01) |
22 | DE application date | DAT | Feb 6, 2019 |
96 | EP application date | EAT | Feb 6, 2019 |
86 | WO application date | WAT | Feb 6, 2019 |
43 | Date of first publication | OT | Aug 15, 2019 |
| Date of publication of grant | PET | Oct 26, 2022 |
71/73 | Applicant/owner | INH | Aegis Therapeutics, LLC, San Diego, CA, US; ARS Pharmaceuticals Operations, Inc. (n.d.Ges.d.Staates Delaware), San Diego, CA, US |
72 | Inventor | IN | LOWENTHAL, Richard, San Diego, California 92127, US; MAGGIO, Edward T., San Diego, California 92121, US; BELL, Robert G., San Diego, California 92127, US; SHAH, Pratik, San Diego, California 92127, US |
74 | Representative | VTR | Mewburn Ellis LLP, 80333 München, DE |
| Address for service | | Mewburn Ellis LLP, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201815890131 Feb 6, 2018
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862685049 P Jun 14, 2018
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862784057 P Dec 21, 2018
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862734550 P Sep 21, 2018
|
| Due date | FT FG | Feb 28, 2026 Annual fee for the 8th year
Patent fees |
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2025 000 010.1 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003678649A1 Searchable text:
EP000003678649A1 Original document:
EP000003678649B1 Searchable text:
EP000003678649B1 Original document:
WO002019157099 Searchable text:
WO002019157099 |
43 | Date of first publication | EVT | Aug 15, 2019 |
| Date of the first transfer into DPMAregister | EREGT | Jul 14, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 11, 2025 (Show all update days)(Hide all update days)- Mar 11, 2025
- Feb 27, 2025
- File number of protection certificate: new
- Sep 3, 2024
- St.36: changed (technical change)
- Jul 11, 2024; Mar 5, 2024; Aug 24, 2023; Aug 10, 2023; Jun 8, 2023; May 23, 2023; Feb 2, 2023; Jan 5, 2023; Nov 4, 2022; Oct 20, 2022; Oct 6, 2022; Jul 16, 2020
- Historical data not available for this/these date(s)
- Jul 14, 2020
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | May 22, 2023 |
| Issue number | HN | 26 |
| Year | PJ | 2023 |
| Publication date | VT | Jun 29, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Aegis Therapeutics, LLC, San Diego, CA, US; ARS Pharmaceuticals Operations, Inc. (n.d.Ges.d.Staates Delaware), San Diego, CA, US |
71/73 | Previous applicant/owner | INHF | Aegis Therapeutics, LLC, San Diego, CA, US, ARS Pharmaceuticals Inc., San Diego, CA, US |
| Date of update of the procedure | REGT | Jun 8, 2023 |